Effects of menstrual cycle phase and oral contraceptive use on intermittent exercise

1998 ◽  
Vol 78 (6) ◽  
pp. 565-572 ◽  
Author(s):  
N. J. Lynch ◽  
M. A. Nimmo
Keyword(s):  
Oral Contraceptive ◽  
Menstrual Cycle ◽  
Contraceptive Use ◽  
Intermittent Exercise ◽  
Cycle Phase ◽  
Menstrual Cycle Phase ◽  
Oral Contraceptive Use

No Effect of Menstrual Cycle Phase and Oral Contraceptive Use on Endurance Performance in Rowers

2011 ◽  
Vol 25 (6) ◽  
pp. 1571-1578 ◽  
Author(s):  
Sille Vaiksaar ◽  
Jaak Jürimäe ◽  
Jarek Mäestu ◽  
Priit Purge ◽  
Svetlana Kalytka ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Menstrual Cycle ◽  
Contraceptive Use ◽  
Endurance Performance ◽  
Cycle Phase ◽  
Menstrual Cycle Phase ◽  
Oral Contraceptive Use

Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use

Neurology ◽  
2009 ◽  
Vol 72 (10) ◽  
pp. 911-914 ◽  
Author(s):  
A. G. Herzog ◽  
A. S. Blum ◽  
E. L. Farina ◽  
X. E. Maestri ◽  
J. Newman ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Menstrual Cycle ◽  
Contraceptive Use ◽  
Cycle Phase ◽  
Level Variation ◽  
Menstrual Cycle Phase ◽  
Oral Contraceptive Use

Fatty acid reesterification but not oxidation is increased by oral contraceptive use in women

2005 ◽  
Vol 98 (5) ◽  
pp. 1720-1731 ◽  
Author(s):  
Kevin A. Jacobs ◽  
Gretchen A. Casazza ◽  
Sang-Hoon Suh ◽  
Michael A. Horning ◽  
George A. Brooks
Keyword(s):  
Fatty Acid ◽  
Oral Contraceptive ◽  
Menstrual Cycle ◽  
Contraceptive Use ◽  
Peak Oxygen Consumption ◽  
Cycle Phase ◽  
Acid Oxidation ◽  
Menstrual Cycle Phase ◽  
Oral Contraceptive Use ◽  
Plasma Ffa

We evaluated the hypothesis that fatty acid reesterification would be increased during rest and exercise in the midluteal menstrual cycle phase and during oral contraceptive use, when ovarian hormone concentrations are high, compared with the early follicular phase. Subjects were eight moderately active, weight-stable, eumenorrheic women (24.8 ± 1.2 yr, peak oxygen consumption = 42.0 ± 2.3 ml·kg−1·min−1) who had not taken oral contraceptives for at least 6 mo. Plasma free fatty acid (FFA) kinetics were assessed in the 3-h postprandial state by continuous infusion of [1-13C]palmitate and [1,1,2,3,3-2H]glycerol during 90 min of rest and 60 min of exercise at 45% and 65% peak oxygen consumption in the early follicular and midluteal menstrual cycle phases and during the inactive- and high-dose phases following 4 mo of oral contraceptive use. Plasma FFA rates of appearance, disappearance, and oxidation increased significantly from rest to exercise with no differences noted between menstrual cycle or oral contraceptive phases or exercise intensities. Compared with either menstrual cycle phase, oral contraceptive use resulted in an increase in plasma-derived fatty acid reesterification and a decrease in the proportion of plasma FFA rate of disappearance that was oxidized at rest and during exercise. Endogenous and exogenous synthetic ovarian hormones do not exert a measurable influence on plasma FFA turnover or oxidation at rest or during moderate-intensity exercise in the 3-h postprandial state when carbohydrate use predominates. The increase in whole body lipolytic rate during exercise noted previously with oral contraceptive use is not matched by an increase in fatty acid oxidation and results in an increase in reesterification. Synthetic ovarian hormones contained in oral contraceptives increase lipolytic rate, but fatty acid oxidation during exercise is determined by exercise intensity and its metabolic and endocrine consequences.

Sign in / Sign up

Export Citation Format

Share Document